Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
PTGX - As of  01/26/25, 10:16:13 AM:   41 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for PTGX

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-06-09 16:32:54.0 Protagonist Therapeutics PTGX BlackRock Inc 4.8% view
S 2020-06-08 16:04:49.0 Protagonist Therapeutics PTGX Lilly Ventures Fund I LLC 4.5% view
B 2020-05-22 16:30:49.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 6.39% view
S 2020-02-14 16:09:23.0 Protagonist Therapeutics PTGX Venrock Healthcare Capital Partners II 0.4% view
S 2020-02-14 16:00:33.0 Protagonist Therapeutics PTGX PERCEPTIVE ADVISORS LLC n/a view
S 2020-02-14 14:37:20.0 Protagonist Therapeutics PTGX BIOTECHNOLOGY VALUE FUND L P 8.1% view
B 2020-02-14 13:24:46.0 Protagonist Therapeutics PTGX RTW INVESTMENTS 9.04% view
B 2020-02-14 06:19:18.0 Protagonist Therapeutics PTGX FARALLON CAPITAL MANAGEMENT LLC 9.9% view
B 2020-02-07 11:28:22.0 Protagonist Therapeutics PTGX FMR LLC 14.999% view
B 2020-02-07 08:45:16.0 Protagonist Therapeutics PTGX BlackRock Inc 5.7% view
B 2019-12-16 11:06:23.0 Protagonist Therapeutics PTGX RTW INVESTMENTS 8.04% view
B 2019-07-01 16:49:53.0 Protagonist Therapeutics PTGX INTEGRATED CORE STRATEGIES 3.5% view
B 2019-06-17 16:05:21.0 Protagonist Therapeutics PTGX Venrock Healthcare Capital Partners II 6.4% view
S 2019-02-14 16:34:41.0 Protagonist Therapeutics PTGX GREAT POINT PARTNERS LLC 3.95% view
S 2019-02-14 16:18:37.0 Protagonist Therapeutics PTGX BIOTECHNOLOGY VALUE FUND L P 9.99% view
B 2019-02-13 21:12:16.0 Protagonist Therapeutics PTGX FARALLON CAPITAL MANAGEMENT LLC 9.9% view
S 2019-02-13 13:44:09.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 0.0% view
B 2019-02-13 12:02:31.0 Protagonist Therapeutics PTGX FMR LLC 14.999% view
S 2019-02-05 16:06:01.0 Protagonist Therapeutics PTGX Aisling Capital IV n/a view
S 2019-01-24 13:09:04.0 Protagonist Therapeutics PTGX CANAAN X L 4.5% view
B 2018-12-10 08:30:58.0 Protagonist Therapeutics PTGX PERCEPTIVE ADVISORS LLC 5.3% view
B 2018-08-17 17:40:34.0 Protagonist Therapeutics PTGX FARALLON CAPITAL MANAGEMENT LLC 9.9% view
B 2018-08-10 16:40:26.0 Protagonist Therapeutics PTGX BIOTECHNOLOGY VALUE FUND L P 10.9% view
B 2018-07-02 16:04:26.0 Protagonist Therapeutics PTGX GREAT POINT PARTNERS LLC 6.95% view
B 2018-05-24 16:47:00.0 Protagonist Therapeutics PTGX BIOTECHNOLOGY VALUE FUND L P 6.9% view
S 2018-02-20 18:49:32.0 Protagonist Therapeutics PTGX Pharmstandard International S 4.8% view
B 2018-02-13 09:43:23.0 Protagonist Therapeutics PTGX FMR LLC 14.999% view
S 2018-02-07 16:23:21.0 Protagonist Therapeutics PTGX Aisling Capital IV 5.0% view
S 2018-01-04 09:00:17.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 9.7% view
B 2017-06-01 16:09:01.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 12.2% view
S 2017-02-14 19:13:55.0 Protagonist Therapeutics PTGX RA CAPITAL MANAGEMENT 4.1% view
B 2017-02-14 11:45:16.0 Protagonist Therapeutics PTGX FMR LLC 14.999% view
B 2017-02-13 14:15:08.0 Protagonist Therapeutics PTGX Pharmstandard International S 10.37% view
S 2017-02-09 13:25:21.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 9.16% view
B 2017-01-26 16:47:02.0 Protagonist Therapeutics PTGX CANAAN X L 14.7% view
B 2016-10-11 13:49:13.0 Protagonist Therapeutics PTGX FMR LLC 12.931% view
B 2016-09-12 16:32:36.0 Protagonist Therapeutics PTGX Aisling Capital IV 5.1% view
B 2016-08-26 16:09:57.0 Protagonist Therapeutics PTGX Lilly Ventures Fund I LLC 12.9% view
B 2016-08-25 16:15:44.0 Protagonist Therapeutics PTGX RA CAPITAL MANAGEMENT 6.8% view
B 2016-08-19 11:44:19.0 Protagonist Therapeutics PTGX ADAGE CAPITAL PARTNERS GP 9.69% view
B 2016-08-19 10:25:51.0 Protagonist Therapeutics PTGX JOHNSON & JOHNSON 15.0% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.